{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:40:04Z","timestamp":1788878404607,"version":"build-2803163510"},"reference-count":55,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Cardiol"],"abstract":"<jats:p>Cancer and cardiovascular diseases (CVD) are among the leading causes of death worldwide. In response to the growing population of cancer patients and survivors with CVD, the sub-specialty of cardio-oncology has been developed to better optimise their care. Palpitations are one of the most common presenting complaints seen in the emergency room or by the primary care provider or cardiologist. Palpitations are defined as a rapid pulsation or abnormally rapid or irregular beating of the heart and present a complex diagnostic entity with no evidence-based guidelines currently available. Palpitations are a frequent occurrence in people with cancer, and investigations and treatment are comparable to that in the general population although there are some nuances. Cancer patients are at a higher risk of arrhythmogenic causes of palpitations and \nnon-arrhythmogenic causes of palpitations. This review will appraise the literature with regards to the development and management of palpitations in the cancer patient.<\/jats:p>","DOI":"10.15420\/ecr.2021.44","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T11:39:49Z","timestamp":1638617989000},"source":"Crossref","is-referenced-by-count":7,"title":["Palpitations in the Cancer Patient"],"prefix":"10.15420","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9445-2582","authenticated-orcid":false,"given":"Hani","family":"Essa","sequence":"first","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool Heart and Chest Hospital, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool Heart and Chest Hospital, Liverpool, UK; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Quaresma M, Coleman MP, Rachet B. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971\u20132011: a population-based study. Lancet 2015;385:1206\u201318. https:\/\/doi.org\/10.1016\/S0140-6736(14)61396-9; PMID:\u00a025479696.","DOI":"10.1016\/s0140-6736(14)61396-9"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 2015;132:1667\u201378. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.008720; PMID:\u00a026503749.","DOI":"10.1161\/circulationaha.114.008720"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Ewer MS, Ewer SM. Cardiotoxicity of anticancer treatments. Nat Rev Cardiol 2015;12:547\u20138. https:\/\/doi.org\/10.1038\/nrcardio.2015.65; PMID:\u00a025962976.","DOI":"10.1038\/nrcardio.2015.65"},{"key":"ref3","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572\u201382. https:\/\/doi.org\/10.1056\/NEJMsa060185; PMID:\u00a017035650."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Lenihan DJ, Cardinale D, Cipolla CM. The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society. Prog Cardiovasc Dis 2010;53:88\u201393. https:\/\/doi.org\/10.1016\/j.pcad.2010.06.002l; PMID:\u00a020728695.","DOI":"10.1016\/j.pcad.2010.06.002"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Pareek N, Cevallos J, Moliner P, et al. Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience. Eur J Heart Fail 2018;20:1721\u201331. https:\/\/doi.org\/10.1002\/ejhf.1292; PMID:\u00a030191649.","DOI":"10.1002\/ejhf.1292"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Brugada P, G\u00fcrsoy S, Brugada J, et al. Investigation of palpitations. Lancet 1993;341:1254\u20138. https:\/\/doi.org\/10.1016\/0140-6736(93)91155-F; PMID:\u00a08098401.","DOI":"10.1016\/0140-6736(93)91155-f"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Mayou R. Chest pain, palpitations and panic. J Psychosom Res 1998;44:53\u201370. https:\/\/doi.org\/10.1016\/S0022-3999(97)00209-2; PMID:\u00a09483464.","DOI":"10.1016\/S0022-3999(97)00209-2"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Probst MA, Mower WR, Kanzaria HK, et al. Analysis of emergency department visits for palpitations (from the National Hospital Ambulatory Medical Care Survey). Am J Cardiol 2014;113:1685\u201390. https:\/\/doi.org\/10.1016\/j.amjcard.2014.02.020; PMID:\u00a024698469.","DOI":"10.1016\/j.amjcard.2014.02.020"},{"key":"ref9","unstructured":"Giada F, Raviele A. Diagnostic management of patients with palpitations of unknown origin. Ital Heart J 2004;5:581\u20136. PMID:\u00a015554028."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Raviele A, Giada F, Bergfeldt L, et al. Management of patients with palpitations: a position paper from the European Heart Rhythm Association. Europace 2011;13:920\u201334. https:\/\/doi.org\/10.1093\/europace\/eur130; PMID:\u00a021697315.","DOI":"10.1093\/europace\/eur130"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations. Am J Med 1996;100:138\u201348. https:\/\/doi.org\/10.1016\/S0002-9343(97)89451-X; PMID:\u00a08629647.","DOI":"10.1016\/S0002-9343(97)89451-X"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Thavendiranathan P, Bagai A, Khoo C, et al. Does this patient with palpitations have a cardiac arrhythmia? JAMA 2009;302:2135\u201343. https:\/\/doi.org\/10.1001\/jama.2009.1673; PMID:\u00a019920238.","DOI":"10.1001\/jama.2009.1673"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Hoefman E, Boer KR, van Weert HC, et al. Predictive value of history taking and physical examination in diagnosing arrhythmias in general practice. Fam Pract 2007;24:636\u201341. https:\/\/doi.org\/10.1093\/fampra\/cmm056; PMID:\u00a017986627.","DOI":"10.1093\/fampra\/cmm056"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC\/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology\/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography). Circulation 1999;100:886\u201393. https:\/\/doi.org\/10.1161\/01.CIR.100.8.886; PMID:\u00a010458728.","DOI":"10.1161\/01.cir.100.8.886"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Flaker GC, Belew K, Beckman K, et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:657\u201363. https:\/\/doi.org\/10.1016\/j.ahj.2004.06.032; PMID:\u00a015990749.","DOI":"10.1016\/j.ahj.2004.06.032"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Turakhia MP, Hoang DD, Zimetbaum P, et al. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol 2013;112:520\u20134. https:\/\/doi.org\/10.1016\/j.amjcard.2013.04.017; PMID:\u00a023672988.","DOI":"10.1016\/j.amjcard.2013.04.017"},{"key":"ref17","unstructured":"Guo Y, Wang H, Zhang H, et al. Mobile photoplethysmographic technology to detect atrial fibrillation. J Am Coll Cardiol 2019;74:2365\u201375. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.019; PMID:\u00a031487545."},{"key":"ref18","unstructured":"Perez MV, Mahaffey KW, Hedlin H, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med 2019;381:1909\u201317. https:\/\/doi.org\/10.1056\/NEJMoa1901183; PMID:\u00a031722151."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 2020;42: 373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612; PMID:\u00a032860505.","DOI":"10.1093\/eurheartj\/ehaa945"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Gale CP, Camm AJ. Assessment of palpitations. BMJ 2016;352:h5649. https:\/\/doi.org\/10.1136\/bmj.h5649; PMID:\u00a026739319.","DOI":"10.1136\/bmj.h5649"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Blomstr\u00f6m-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias \u2013 executive summary. a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 2003;42:1493\u2013531. https:\/\/doi.org\/10.1016\/j.jacc.2003.08.013; PMID:\u00a014563598.","DOI":"10.1016\/j.ehj.2003.08.002"},{"key":"ref22","unstructured":"Zipes DP, Camm AJ, Borggrefe M, et al. ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:e247\u2013346. https:\/\/doi.org\/10.1016\/j.jacc.2006.07.010; PMID:\u00a016949478."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Lampert R, Joska T, Burg MM, et al. Emotional and physical precipitants of ventricular arrhythmia. Circulation 2002;106:1800\u20135. https:\/\/doi.org\/10.1161\/01.CIR.0000031733.51374.C1; PMID:\u00a012356633.","DOI":"10.1161\/01.cir.0000031733.51374.c1"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Eaker ED, Sullivan LM, Kelly-Hayes M, et al. Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation 2004;109:1267\u201371. https:\/\/doi.org\/10.1161\/01.CIR.0000118535.15205.8F; PMID:\u00a014993133.","DOI":"10.1161\/01.cir.0000118535.15205.8f"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Spencer R, Nilsson M, Wright A, et al. Anxiety disorders in advanced cancer patients: correlates and predictors of end-of-life outcomes. Cancer 2010;116:1810\u20139. https:\/\/doi.org\/10.1002\/cncr.24954; PMID:\u00a020187099.","DOI":"10.1002\/cncr.24954"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Tamargo J, Caballero R, Delp\u00f3n E. Cancer chemotherapy and cardiac arrhythmias: a review. Drug Saf 2015;38:129\u201352. https:\/\/doi.org\/10.1007\/s40264-014-0258-4; PMID:\u00a025577497.","DOI":"10.1007\/s40264-014-0258-4"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Lee DH, Chandrashekhar S, Fradley MG. Electrophysiologic complications in cancer patients. Methodist Debakey Cardiovasc J 2019;15:282\u201388. https:\/\/doi.org\/10.14797\/mdcj-15-4-282; PMID:\u00a031988689.","DOI":"10.14797\/mdcj-15-4-282"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Die Trill M. Anxiety and sleep disorders in cancer patients. EJC Suppl 2013;11:216\u201324. https:\/\/doi.org\/10.1016\/j.ejcsup.2013.07.009; PMID:\u00a026217130.","DOI":"10.1016\/j.ejcsup.2013.07.009"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Barsky AJ, Ahern DK, Delamater BA, et al. Differential diagnosis of palpitations. Preliminary development of a screening instrument. Arch Fam Med 1997;6:241\u20135. https:\/\/doi.org\/10.1001\/archfami.6.3.241; PMID:\u00a09161349.","DOI":"10.1001\/archfami.6.3.241"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Lessmeier TJ, Gamperling D, Johnson-Liddon V, et al. Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder. Arch Intern Med 1997;157:537\u201343. https:\/\/doi.org\/10.1001\/archinte.1997.00440260085013; PMID:\u00a09066458.","DOI":"10.1001\/archinte.1997.00440260085013"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Buza V, Rajagopalan B, Curtis AB. Cancer treatment-induced arrhythmias: focus on chemotherapy and targeted therapies. Circ Arrhythm Electrophysiol 2017;10:e005443. https:\/\/doi.org\/10.1161\/CIRCEP.117.005443; PMID:\u00a028798022.","DOI":"10.1161\/circep.117.005443"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Guglin M, Aljayeh M, Saiyad S, et al. Introducing a new entity: chemotherapy-induced arrhythmia. Europace 2009;11:1579\u201386. https:\/\/doi.org\/10.1093\/europace\/eup300; PMID:\u00a019801562.","DOI":"10.1093\/europace\/eup300"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Lee CS, Rattu MA, Kim SS. A review of a novel, Bruton\u2019s tyrosine kinase inhibitor, ibrutinib. J Oncol Pharm Pract 2016;22:92\u2013104. https:\/\/doi.org\/10.1177\/1078155214561281; PMID:\u00a025425007.","DOI":"10.1177\/1078155214561281"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Brown JR, Moslehi J, O\u2019Brien S, et al. Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials. Haematologica 2017;102:1796\u2013805. https:\/\/doi.org\/10.3324\/haematol.2017.171041; PMID:\u00a028751558.","DOI":"10.3324\/haematol.2017.171041"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Mato AR, Nabhan C, Barr PM, et al. Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience. Blood 2016;128:2199\u2013205. https:\/\/doi.org\/10.1182\/blood-2016-05-716977; PMID:\u00a027601462.","DOI":"10.1182\/blood-2016-05-716977"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Thorp BC, Badoux X. Atrial fibrillation as a complication of ibrutinib therapy: clinical features and challenges of management. Leuk Lymphoma 2018;59:311\u201320. https:\/\/doi.org\/10.1080\/10428194.2017.1339874; PMID:\u00a028629235.","DOI":"10.1080\/10428194.2017.1339874"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Ganatra S, Sharma A, Shah S, et al. Ibrutinib-associated atrial fibrillation. JACC Clin Electrophysiol 2018;4:1491\u2013500. https:\/\/doi.org\/10.1016\/j.jacep.2018.06.004; PMID:\u00a030573111.","DOI":"10.1016\/j.jacep.2018.06.004"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Essa H, Lodhi T, Dobson R, et al. How to manage atrial fibrillation secondary to ibrutinib. JACC CardiacOncol 2021;3:140\u20134. https:\/\/doi.org\/10.1016\/j.jaccao.2020.11.016; PMID:\u00a034396314.","DOI":"10.1016\/j.jaccao.2020.11.016"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Barbey JT, Pezzullo JC, Soignet SL. Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol 2003;21:3609\u201315. https:\/\/doi.org\/10.1200\/JCO.2003.10.009; PMID:\u00a014512391.","DOI":"10.1200\/jco.2003.10.009"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Ohnishi K, Yoshida H, Shigeno K, et al. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med 2000;133:881\u00ad\u20135. https:\/\/doi.org\/10.7326\/0003-4819-133-11-200012050-00012; PMID:\u00a011103058.","DOI":"10.7326\/0003-4819-133-11-200012050-00012"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Siu CW, Au WY, Yung C, et al. Effects of oral arsenic trioxide therapy on QT intervals in patients with acute promyelocytic leukemia: implications for long-term cardiac safety. Blood 2006;108:103\u20136. https:\/\/doi.org\/10.1182\/blood-2006-01-0054; PMID:\u00a016514059.","DOI":"10.1182\/blood-2006-01-0054"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Soignet SL, Frankel SR, Douer D, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 2001;19:3852\u201360. https:\/\/doi.org\/10.1200\/JCO.2001.19.18.3852; PMID:11559723.","DOI":"10.1200\/jco.2001.19.18.3852"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Westervelt P, Brown RA, Adkins DR, et al. Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood 2001;98:266\u201371. https:\/\/doi.org\/10.1182\/blood.V98.2.266; PMID:\u00a011435292.","DOI":"10.1182\/blood.v98.2.266"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Mac\u00edas Gallego A, D\u00edaz-Infante E, Garc\u00eda-Bolao I. Spanish Catheter Ablation Registry. 8th official report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2008). Rev Esp Cardiol 2009;62:1276\u201385. https:\/\/doi.org\/10.1016\/S1885-5857(09)73355-9; PMID:\u00a019889339.","DOI":"10.1016\/s1885-5857(09)73355-9"},{"key":"ref45","unstructured":"Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2007;28:2375\u2013414. https:\/\/doi.org\/10.1093\/eurheartj\/ehm316; PMID:\u00a017726041."},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Jouven X, Zureik M, Desnos M, et al. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med 2000;343:826\u201333. https:\/\/doi.org\/10.1056\/NEJM200009213431201; PMID:\u00a010995861.","DOI":"10.1056\/nejm200009213431201"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Binici Z, Intzilakis T, Nielsen OW, et al. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 2010;121:1904\u201311. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.874982; PMID:\u00a020404258.","DOI":"10.1161\/circulationaha.109.874982"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Farmakis D, Parissis J, Filippatos G. Insights into onco-cardiology: atrial fibrillation in cancer. J Am Coll Cardiol 2014;63:945\u201353. https:\/\/doi.org\/10.1016\/j.jacc.2013.11.026; PMID:\u00a024361314.","DOI":"10.1016\/j.jacc.2013.11.026"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Fern\u00e1ndez T, Mart\u00edn-Garc\u00eda A, Rold\u00e1n Rabad\u00e1n I, et al. Atrial fibrillation in active cancer patients: expert position paper and recommendations. Rev Esp Cardiol (Engl Ed 2019;72:749\u201359. https:\/\/doi.org\/10.1016\/j.rec.2019.03.019; PMID:\u00a031405794.","DOI":"10.1016\/j.rec.2019.03.019"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Lee AY. Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices. Dis Mon 2005;51:150\u20137. https:\/\/doi.org\/10.1016\/j.disamonth.2005.03.010; PMID:\u00a015900267.","DOI":"10.1016\/j.disamonth.2005.03.010"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016;37:2768\u2013801. https:\/\/doi.org\/10.1093\/eurheartj\/ehw211; PMID:\u00a027567406.","DOI":"10.1093\/eurheartj\/ehw211"},{"key":"ref52","unstructured":"Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018;39:1330\u201393. https:\/\/doi.org\/10.1093\/eurheartj\/ehy136; PMID:\u00a029562325."},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Shah S, Norby FL, Datta YH, et al. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. Blood Adv 2018;2:200\u20139. https:\/\/doi.org\/10.1182\/bloodadvances.2017010694; PMID:\u00a029378726.","DOI":"10.1182\/bloodadvances.2017010694"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Giustozzi M, Ali H, Reboldi G, et al. Safety of catheter ablation of atrial fibrillation in cancer survivors. J Interv Card Electrophysiol 2021;60:419\u201326. https:\/\/doi.org\/10.1007\/s10840-020-00745-7; PMID:\u00a032377917.","DOI":"10.1007\/s10840-020-00745-7"}],"container-title":["European Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2021.44","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T11:39:57Z","timestamp":1638617997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ecrjournal.com\/articleindex\/ecr.2021.44"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":55,"URL":"https:\/\/doi.org\/10.15420\/ecr.2021.44","relation":{},"ISSN":["1758-3764","1758-3756"],"issn-type":[{"value":"1758-3764","type":"electronic"},{"value":"1758-3756","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"article-number":"e45"}}